Table of Contents Author Guidelines Submit a Manuscript
Contrast Media & Molecular Imaging
Volume 2018, Article ID 5362329, 9 pages
https://doi.org/10.1155/2018/5362329
Research Article

One-Step 18F-Labeling of Estradiol Derivative for PET Imaging of Breast Cancer

Key Laboratory of Nuclear Medicine of Ministry of Health and Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China

Correspondence should be addressed to Ling Qiu; gro.mnisj@gniluiq and Jianguo Lin; gro.mnisj@ougnaijnil

Received 19 September 2017; Accepted 17 January 2018; Published 5 March 2018

Academic Editor: Yuebing Wang

Copyright © 2018 Hongbo Huang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, and J. Lortet-Tieulent, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar
  2. K. Chauhan, A. Arun, S. Singh et al., “Bivalent Approach for Homodimeric Estradiol Based Ligand: Synthesis and Evaluation for Targeted Theranosis of ER(+) Breast Carcinomas,” Bioconjugate Chemistry, vol. 27, no. 4, pp. 961–972, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. J. N. Bharti, P. Rani, V. Kamal, and P. N. Agarwal, “Angiogenesis in breast cancer and its correlation with estrogen, Progesterone receptors and other prognostic factors,” Journal of Clinical and Diagnostic Research, vol. 9, no. 1, pp. EC05–EC07, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. H. M. Linden and F. Dehdashti, “Novel methods and tracers for breast cancer imaging,” Seminars in Nuclear Medicine, vol. 43, pp. 324–329, 2013. View at Google Scholar
  5. A. C. Tecalco-Cruz, I. A. Pérez-Alvarado, J. O. Ramírez-Jarquín, and L. Rocha-Zavaleta, “Nucleo-cytoplasmic transport of estrogen receptor alpha in breast cancer cells,” Cellular Signalling, vol. 34, pp. 121–132, 2017. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Losurdo, S. Rota, G. Gullo et al., “Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: A review of the literature,” Critical Review in Oncology/Hematology, vol. 113, pp. 283–291, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Xia, H. Feng, C. Li, C. Qin, Y. Song, Y. Zhang et al., “99mTc-labeled estradiol as an estrogen receptor probe: Preparation and preclinical evaluation,” Nuclear Medicine and Biology, vol. 43, pp. 89–96, 2016. View at Google Scholar
  8. C. S. Kue, A. Kamkaew, K. Burgess, L. V. Kiew, L. Y. Chung, and H. B. Lee, “Small Molecules for Active Targeting in Cancer,” Medicinal Research Reviews, vol. 36, no. 3, pp. 494–575, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Liu, K.-S. Lin, F. Bénard et al., “One-step 18 F labeling of biomolecules using organotrifluoroborates,” Nature Protocols, vol. 10, no. 9, pp. 1423–1432, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Liu, M. Pourghiasian, M. A. Radtke et al., “An organotrifluoroborate for broadly applicable one-step18F-labeling,” Angewandte Chemie International Edition, vol. 53, no. 44, pp. 11876–11880, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Lin, W. Wang, K. Li et al., “Development of a kit-like radiofluorinated biomolecule leading to a controlled self-assembly of 18F nanoparticles for a smart PET imaging application,” Chemical Communications, vol. 53, no. 48, pp. 6476–6479, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Shen, J. Jeon, M. Palner et al., “Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-triggered nanoaggregation probe,” Angewandte Chemie International Edition, vol. 52, no. 40, pp. 10511–10514, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Liu, W. Wang, J. Lin, K. Li, G. Lv, and X. Zhao, “Kit-like 18F-labeling of an estradiol derivative as a potential PET imaging agent for estrogen receptor-positive breast cancer,” Journal of Radioanalytical and Nuclear Chemistry, pp. 1–9, 2017. View at Google Scholar
  14. Z. Liu, Y. Li, J. Lozada et al., “Kit-like 18F-labeling of RGD-19F-Arytrifluroborate in high yield and at extraordinarily high specific activity with preliminary in vivo tumor imaging,” Nuclear Medicine and Biology, vol. 40, no. 6, pp. 841–849, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. F. F. An, H. Kommidi, N. Chen, and R. Ting, “A conjugate of pentamethine cyanine and18F as a positron emission tomography/near-infrared fluorescence probe for multimodality tumor imaging,” International Journal of Molecular Sciences, vol. 18, no. 6, article no. 1214, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Yoo, C. S. Dence, T. L. Sharp, J. A. Katzenellenbogen, and M. J. Welch, “Synthesis of an estrogen receptor β-selective radioligand: 5-[ 18F]fluoro-(2R*,3S*)-2,3-bis(4-hydroxyphenyl) pentanenitrile and comparison of in vivo distribution with 16α-[ 18F]fluoro-17β-estradiol,” Journal of Medicinal Chemistry, vol. 48, no. 20, pp. 6366–6378, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. Zhao, Y. Yoshida, T. Kurokawa, Y. Kiyono, T. Mori, and H. Okazawa, “18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: Correlation with immunohistochemical analysis,” Journal of Nuclear Medicine, vol. 54, no. 4, pp. 499–506, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Mori, S. Kasamatsu, C. Mosdzianowski, M. J. Welch, Y. Yonekura, and Y. Fujibayashi, “Automatic synthesis of 16α-[18F]fluoro-17β-estradiol using a cassette-type [18F]fluorodeoxyglucose synthesizer,” Nuclear Medicine and Biology, vol. 33, no. 2, pp. 281–286, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. N. Nosova, L. S. Foteeva, and I. V. Zenin, “Enhancing the Cytotoxic Activity of Anticancer PtIV Complexes by Introduction of Lonidamine as an Axial Ligand,” European Journal of Inorganic Chemistry, vol. 12, pp. 1785–1791, 2017. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Dong, S. Yang, J. Shi et al., “SPECT/NIRF Dual Modality Imaging for Detection of Intraperitoneal Colon Tumor with an Avidin/Biotin Pretargeting System,” Scientific Reports, vol. 6, Article ID 18905, 2016. View at Publisher · View at Google Scholar · View at Scopus